96 related articles for article (PubMed ID: 23066917)
1. Low-density lipoprotein levels in patients with acute heart failure.
Kahn MR; Kosmas CE; Wagman G; Serrao GW; Fallahi A; Grady KM; Vittorio TJ
Congest Heart Fail; 2013; 19(2):85-91. PubMed ID: 23066917
[TBL] [Abstract][Full Text] [Related]
2. Baseline low-density lipoprotein cholesterol levels and outcome in patients with heart failure.
Charach G; George J; Roth A; Rogowski O; Wexler D; Sheps D; Grosskopf I; Weintraub M; Keren G; Rubinstein A
Am J Cardiol; 2010 Jan; 105(1):100-4. PubMed ID: 20102899
[TBL] [Abstract][Full Text] [Related]
3. Recovery of Serum Cholesterol Predicts Survival After Left Ventricular Assist Device Implantation.
Vest AR; Kennel PJ; Maldonado D; Young JB; Mountis MM; Naka Y; Colombo PC; Mancini DM; Starling RC; Schulze PC
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623768
[TBL] [Abstract][Full Text] [Related]
4. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.
Horwich TB; MacLellan WR; Fonarow GC
J Am Coll Cardiol; 2004 Feb; 43(4):642-8. PubMed ID: 14975476
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoprotein cholesterol levels and prognosis in advanced heart failure.
Mehra MR; Uber PA; Lavie CJ; Milani RV; Park MH; Ventura HO
J Heart Lung Transplant; 2009 Sep; 28(9):876-80. PubMed ID: 19716038
[TBL] [Abstract][Full Text] [Related]
6. Undertreatment of hyperlipidemia in patients with coronary artery disease and heart failure.
Sueta CA; Massing MW; Chowdhury M; Biggs DP; Simpson RJ
J Card Fail; 2003 Feb; 9(1):36-41. PubMed ID: 12612871
[TBL] [Abstract][Full Text] [Related]
7. [Benefits of statin therapy based on plasma carbohydrate antigen 125 values following an admission for acute heart failure].
Núñez J; Sanchis J; Núñez E; Fonarow GC; Bodí V; Bertomeu-González V; Miñana G; Palau P; Fácila L; Chorro FJ; Bertomeu-Martínez V; Llàcer A
Rev Esp Cardiol; 2011 Dec; 64(12):1100-8. PubMed ID: 21958731
[TBL] [Abstract][Full Text] [Related]
8. Low cholesterol, statins and outcomes in patients with first-ever acute ischemic stroke.
Koton S; Molshatzki N; Bornstein NM; Tanne D
Cerebrovasc Dis; 2012; 34(3):213-20. PubMed ID: 23006641
[TBL] [Abstract][Full Text] [Related]
9. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
Shah R; Wang Y; Foody JM
Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
[TBL] [Abstract][Full Text] [Related]
10. Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report.
Fukuta H; Sane DC; Brucks S; Little WC
Circulation; 2005 Jul; 112(3):357-63. PubMed ID: 16009792
[TBL] [Abstract][Full Text] [Related]
11. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
Ueland T; Dahl CP; Kjekshus J; Hulthe J; Böhm M; Mach F; Goudev A; Lindberg M; Wikstrand J; Aukrust P; Gullestad L
Circ Heart Fail; 2011 Mar; 4(2):145-52. PubMed ID: 21216833
[TBL] [Abstract][Full Text] [Related]
12. The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease.
Feringa HH; Karagiannis SE; van Waning VH; Boersma E; Schouten O; Bax JJ; Poldermans D
J Vasc Surg; 2007 May; 45(5):936-43. PubMed ID: 17360142
[TBL] [Abstract][Full Text] [Related]
13. Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival.
Leeper NJ; Ardehali R; deGoma EM; Heidenreich PA
Circulation; 2007 Aug; 116(6):613-8. PubMed ID: 17664373
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin in older patients with systolic heart failure.
Kjekshus J; Apetrei E; Barrios V; Böhm M; Cleland JG; Cornel JH; Dunselman P; Fonseca C; Goudev A; Grande P; Gullestad L; Hjalmarson A; Hradec J; Jánosi A; Kamenský G; Komajda M; Korewicki J; Kuusi T; Mach F; Mareev V; McMurray JJ; Ranjith N; Schaufelberger M; Vanhaecke J; van Veldhuisen DJ; Waagstein F; Wedel H; Wikstrand J;
N Engl J Med; 2007 Nov; 357(22):2248-61. PubMed ID: 17984166
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H;
Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314
[TBL] [Abstract][Full Text] [Related]
16. Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level.
Bleske BE; Nicklas JM; Bard RL; Brook RD; Gurbel PA; Bliden KP; Rajagopalan S; Pitt B
J Am Coll Cardiol; 2006 Jan; 47(2):338-41. PubMed ID: 16412857
[TBL] [Abstract][Full Text] [Related]
17. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
Spencer FA; Goldberg RJ; Gore JM; Fox KA; Avezum A; Agnelli G; Kritharides L; Anderson FA; Goodman SG; FitzGerald G; Allegrone J; Brieger D;
Am J Cardiol; 2007 Sep; 100(6):913-8. PubMed ID: 17826369
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).
Greene SJ; Vaduganathan M; Lupi L; Ambrosy AP; Mentz RJ; Konstam MA; Nodari S; Subacius HP; Fonarow GC; Bonow RO; Gheorghiade M;
Am J Cardiol; 2013 Feb; 111(4):574-81. PubMed ID: 23206923
[TBL] [Abstract][Full Text] [Related]
19. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
[TBL] [Abstract][Full Text] [Related]
20. Statins in ischemic stroke: just low-density lipoprotein lowering or more?
Stead LG; Vaidyanathan L; Kumar G; Bellolio MF; Brown RD; Suravaram S; Enduri S; Gilmore RM; Decker WW
J Stroke Cerebrovasc Dis; 2009; 18(2):124-7. PubMed ID: 19251188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
